Schedule 13G ownership disclosure
PROTEOSTASIS THERAPEUTICS, INC.
Security class unavailable · CUSIP: 74373B109
Event date: 2018-10-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,962,962
- Percent of class
- 6.2200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-18-003265
- Form type
- SC 13G
- Filer
- GREAT POINT PARTNERS LLC
- CIK
- CIK 1281446
- Filed
- Nov 05, 2018
- Reporting period
- Oct 24, 2018
- Description
- Schedule 13G beneficial ownership